Reaction
Laryngomalacia reporting signals
As of the last recalculation, Laryngomalacia appears in 334 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is NEVIRAPINE (PRR 162.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nevirapine | 22 | 162.6 | 163.0 |
| Darunavir | 26 | 116.1 | 116.3 |
| Ritonavir 100 Mg | 21 | 93.4 | 93.5 |
| Ritonavir | 26 | 60.0 | 60.1 |
| Tenofovir Disoproxil Fumarate Tablets | 8 | 59.1 | 59.2 |
| Raltegravir | 13 | 51.0 | 51.1 |
| Norepinephrine | 8 | 47.8 | 47.8 |
| Palivizumab | 11 | 46.1 | 46.1 |
| Norepinephrine Bitartrate | 10 | 44.6 | 44.6 |
| Ledipasvir And Sofosbuvir | 13 | 43.8 | 43.8 |
| Methadone | 26 | 41.0 | 41.0 |
| Phenobarbital | 9 | 39.7 | 39.8 |
| Tenofovir Disoproxil Fumarate | 11 | 21.4 | 21.4 |
| Vigabatrin | 3 | 12.9 | 12.9 |